CAPPED BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000KH21DG6

Market Closed - Deutsche Boerse AG 11:06:51 31/05/2024 pm IST
43.29 EUR +0.02% Intraday chart for CAPPED BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE
1 month+2.24%
3 months+12.79%
Date Price Change
31/24/31 43.29 +0.02%
30/24/30 43.28 +0.05%
29/24/29 43.26 -0.02%
28/24/28 43.27 +0.05%
27/24/27 43.25 +0.09%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 11:06 pm IST

More quotes

Static data

Product typeBonus- und Teilschutz-Zertifikate
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Citi Citi
WKN KH21DG
ISINDE000KH21DG6
Date issued 30/01/2023
Strike 43.5
Maturity 20/06/2024 (19 Days)
Parity 1 : 1
Emission price 32.67
Emission volume N/A
Settlement Beides
Currency EUR

Technical Indicators

Highest since issue 43.32
Lowest since issue 32.23

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.18 EUR
Average target price
39.92 EUR
Spread / Average Target
+1.89%
Consensus